Singapore, May 15 -- NinaMED, a newly formed Australian medical device company, has announced its establishment and $13.75 million (AUD $19 million) in financing led by SPRIM Global Investments (SGI). NinaMED holds an exclusive license from Toronto-based EBT Medical to develop and commercialise the NiNA System(R)- non-invasive, at-home, drug-free, therapy for overactive bladder (OAB).

The NiNA System(R) is a non-invasive, wearable neuromodulation system that uses proprietary technology to activate NinaMED's patented saphenous nerve target. The novel patient-centric design enables convenient, in-home treatment sessions while significantly and persistently delivering reduced symptoms of OAB.

Established and headquartered in Melbourne, Nin...